Being the focal point of our international operations, we manufacture and supply a wide range of generics and branded formulations in the United States. Our primary subsidiary, Ascend is ranked among the fastest-growing companies in terms of generic drugs sales.
Our other assets include Norac Pharma in California for API manufacturing.
Our commitment to research has led us to cumulatively file over 144 ANDAs with the US FDA. Our products are available at major pharmacy chains, wholesalers, managed care companies, distributors, and pharmaceutical retailers.
For more information about Alkem's operations in the US, please visit
https://www.ascendlaboratories.com/